Article
Distinct evolutionary patterns of tumour-immune escape and elimination determined by extracellular matrix architectures
1 Jul 2025
Abstract excerpt
Cancer progression remains a significant clinical challenge. Phenotypic adaptation by tumour cells results in disease heterogeneity, which drives treatment resistance and immune escape. T-cell immunotherapy, while effective at treating some cancer subtypes, can also fail due to limits on tumour immunogenicity or T-cell recognition. For example, one potential contributor to immune escape involves the density and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
